Tamparong, Kathriena .

HRN: 25-21-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2026
CEFUROXIME 1.5GM (VIAL)
01/26/2026
01/26/2026
IV
1.5g
PTOR
For D & C
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Compliant To Guidelines